★ Licensed clinicians only

Clinical calculations.
Confident decisions.

Evidence-based tools for dosing, monitoring, and patient care.

Calculators & Toolkits
Renal Function
CrCl + eGFR · cystatin C · BSA-adjusted estimates
Vancomycin AUC
AUC-guided · peak/trough PK · loading dose
 BETA
Acid–Base
ABG + BMP · anion gap · delta-delta · compensation
Aminoglycosides
Hartford nomogram · extended / traditional interval
Anticoagulation
CHA₂DS₂-VASc · HAS-BLED · DOAC · reversal · HIT
 BETA
QT/QTc Assessment
Formula comparison · AF · wide QRS · serial change
Pain Management
MME · rotation · IV→PO conversion
COMING SOON
Clinical Scores
Risk scores · severity tools · steroid conversion
COMING SOON
Clinical Topics
Critical care · cardiology · ID · nephrology
From The Pulse See all updates ›
Infectious Disease FDA approves Bixlenvo — once-daily bictegravir/lenacapavir switch regimen for virologically suppressed adults. Cardiology FDA approves Lipfendra — the first oral PCSK9 inhibitor; LDL lowered ~56–59% in late-stage trials. Infectious Disease Cyclosporiasis — 2026 U.S. multistate outbreak: 6,707 lab-confirmed across 45 states (>11,500 under review); TMP–SMX remains the drug of choice.
Clinical Resources Guidelines, source documents, and clinical references
Built by pharmacists
For real-world practice
Evidence-based
Peer-reviewed sources
Private
No data stored

For licensed clinicians only.

TheraCALC supports clinical decision-making and does not replace clinical judgment or patient-specific assessment. Results and any recommendations are not patient-care orders.

Verify inputs and review results and any recommendations for applicability to the individual patient, considering current clinical guidance and applicable institutional protocols before use.